Evidence map›Paper›PMID 38429784›Full record

ArticleBMC public health2024

Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.

Ethel Tekpor, Kofi Effah, Jerry Sifa, Joseph Emmanuel Amuah, Nana Owusu Mensah Essel, Seyram Kemawor, Comfort Mawusi Wormenor, Edna Sesenu, Stephen Danyo, Patrick Kafui Akakpo

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Risk Factors for Cervical Cancer in Ghana.Cancer reports (Hoboken, N.J.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ethel TekporCervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana.
Kofi EffahCervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana.
Jerry SifaUniversity Health Services, University of Ghana, Accra, Ghana.
Joseph Emmanuel AmuahCervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana.
Nana Owusu Mensah EsselCervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana. nanaowus@ualberta.ca.
Seyram KemaworCervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana.
Comfort Mawusi WormenorCervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana.
Edna SesenuCervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana.
Stephen DanyoCervical Cancer Prevention and Training Centre, Catholic Hospital, Battor, Ghana.
Patrick Kafui AkakpoDepartment of Pathology, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.
Catholic University College of Ghana · GHUniversity of Cape Coast · GHUniversity of Ghana · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle attention has been given to the risk of high-risk human papillomavirus (hr-HPV) infection and cervical precancerous lesions among female migrant head porters (kayayei) in Ghana, as a vulnerable group, and to promote cervical screening in these women. This pilot study aimed to determine the prevalence of hr-HPV infection and cervical lesions among kayayei in Accra, the capital of the Greater Accra Region of Ghana and to describe our approach to triaging and treating these women.

methodsThis descriptive cross-sectional cohort study involved the screening of 63 kayayei aged ≥ 18 years at the Tema Station and Agbogbloshie markets in March 2022 and May 2022. Concurrent hr-HPV DNA testing (with the MA-6000 platform) and visual inspection with acetic acid (VIA) was performed. We present prevalence estimates for hr-HPV DNA positivity and VIA 'positivity' as rates, together with their 95% confidence intervals (CIs). We performed univariate and multivariable nominal logistic regression to explore factors associated with hr-HPV infection.

resultsGross vulvovaginal inspection revealed vulval warts in 3 (5.0%) and vaginal warts in 2 (3.3%) women. Overall, the rate of hr-HPV positivity was 33.3% (95% CI, 21.7-46.7), whereas the VIA 'positivity' rate was 8.3% (95% CI, 2.8-18.4). In the univariate logistic regression analysis, none of the sociodemographic and clinical variables assessed, including age, number of prior pregnancies, parity, past contraceptive use, or the presence of abnormal vaginal discharge showed statistically significant association with hr-HPV positivity. After controlling for age and past contraceptive use, only having fewer than two prior pregnancies (compared to having ≥ 2) was independently associated with reduced odds of hr-HPV infection (adjusted odds ratio, 0.11; 95% CI, 0.02-0.69).

conclusionIn this relatively young cohort with a high hr-HPV positivity rate of 33.3% and 8.3% of women showing cervical lesions on visual inspection, we posit that kayayei may have an increased risk of developing cervical cancer if their accessibility to cervical precancer screening services is not increased.

Indexed as

Condylomata AcuminataPapillomavirus InfectionsTransients and MigrantsUterine Cervical NeoplasmsAcetic AcidContraceptive AgentsCross-Sectional StudiesDNA, ViralEarly Detection of CancerFemaleGhanaHumansPilot ProjectsPregnancyPrevalenceRisk FactorsAcetic AcidContraceptive AgentsDNA, ViralCancer screeningCervical cancerHealth equalityHuman papillomavirus infectionsInternal migrant workersWomen’s health

Identifiers

PMID38429784
PMCPMC10905842
OpenAlexW4392355424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.